ArticleJournal of Cancer2017

Synergy of purine-scaffold TLR7 agonist with doxorubicin on systemic inhibition of lymphoma in mouse model.

Dong Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.